September 11, 2019

James Barry
President and Chief Executive Officer
InspireMD, Inc.
4 Menorat Hemaor Street
Tel Aviv, Israel 6744832

       Re: InspireMD, Inc.
           Registration Statement on Form S-1
           Filed August 23, 2019
           File No. 333-233432

Dear Dr. Barry:

       We have limited our review of your registration statement to those
issues we have
addressed in our comments. In some of our comments, we may ask you to provide
us with
information so we may better understand your disclosure.

       Please respond to this letter by amending your registration statement
and providing the
requested information. If you do not believe our comments apply to your facts
and
circumstances or do not believe an amendment is appropriate, please tell us why
in your
response.

       After reviewing any amendment to your registration statement and the
information you
provide in response to these comments, we may have additional comments.

Form S-1 filed August 23, 2019

Fee Table, page 1

1.     It appears that it is possible that investors may choose to purchase
units or pre-funded
       units. Please revise your table to reflect the maximum amount of each
class of security
       that you are offering and might sell in this transaction, including the
total number of
       common shares underlying the warrants included in the units and the
total number of
       common shares underlying the warrants in the pre-funded units.
2.     Please clarify the reference to $5,750,000 in note 2, given the maximum
aggregate
       offering price currently listed in the fee table.
Prospectus cover page, page 1
 James Barry
InspireMD, Inc.
September 11, 2019
Page 2
3.    Please revise your prospectus cover page to describe clearly the total
number of securities
      you are offering and the total number of securities you intend to sell.
4.    Your disclosure on page 50 indicates that the underwriter is obligated to
purchase and pay
      for all of the units and pre-funded units offered by this prospectus.
Given this, please
      clarify your disclosure, such as here, stating that you are offering "up
to" an unspecified
      number of units and pre-funded units. Explain in more detail how the
structure of this
      offering can be characterized as a "firm commitment" given the apparent
uncertainty at
      the time of effectiveness about the number of each type of security that
the underwriter
      will purchase from you. Explain to us the expected mechanics of the sale
and related
      prospectus cover page and other impacted disclosure.
        We remind you that the company and its management are responsible for
the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action
or absence of
action by the staff.

       Refer to Rules 460 and 461 regarding requests for acceleration. Please
allow adequate
time for us to review any amendment prior to the requested effective date of
the registration
statement.

        Please contact Geoff Kruczek, Special Counsel, at (202) 551-3641 or
Amanda Ravitz,
Assistant Director, at (202) 551-3412 with any other questions.



                                                           Sincerely,
FirstName LastNameJames Barry
                                                           Division of
Corporation Finance
Comapany NameInspireMD, Inc.
                                                           Office of
Electronics and Machinery
September 11, 2019 Page 2
cc:       Rick Werner, Esq.
FirstName LastName